PTC Therapeutics Inc. buy Quitte
Start price
03.03.16
/
50%
€5.86
Target price
05.09.16
€8.03
Performance (%)
21.69%
End price
05.09.16
€7.13
Summary
This prediction ended on 05.09.16 with a price of €7.13. The BUY prediction by Quitte finished with a performance of 21.69%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
PTC Therapeutics Inc. | 6.993% | 6.993% | -11.561% | -15.000% |
iShares Core DAX® | 1.776% | 3.175% | 14.882% | 17.660% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% | 52.324% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% | 11.459% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% | 47.441% |
Comments by Quitte for this prediction
In the thread PTC Therapeutics Inc. diskutieren
chancenreich
die ist nicht so schlecht wie der Absturz vermuten lässt
PTC Therapeutics (NASDAQ: PTCT) recently received a number of ratings updates from brokerages and research firms:
- 3/1/2016 – PTC Therapeutics had its price target raised by analysts at Barclays from $40.00 to $100.00. They now have an “overweight” rating on the stock.
- 3/1/2016 – PTC Therapeutics had its “outperform” rating reaffirmed by analysts at Credit Suisse. They now have a $12.00 price target on the stock, down previously from $36.00. etc etc
(Laufzeit überschritten)